Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Index
-
Market Cap
39.52M
Enterprise Value
36.47M
Income
0.78M
Sales
19.12M
Book/sh
0.99
Cash/sh
0.37
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
36
IPO
Sep 21, 2004
P/E
51.49
Forward P/E
36.40
PEG
-
P/S
2.07
P/B
3.69
P/C
9.83
P/FCF
23.95
EV/EBITDA
45.02
EV/Sales
1.91
Quick Ratio
3.12
Current Ratio
4.55
Debt/Eq
0.09
LT Debt/Eq
0.05
Option/Short
No / Yes
EPS (ttm)
0.07
EPS next Y
0.10
EPS next Q
0.00
EPS this Y
-59.09%
EPS next Y
122.22%
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
23.50% 17.02%
EPS Y/Y TTM
-3.31%
Sales Y/Y TTM
23.25%
EPS Q/Q
-75.86%
Sales Q/Q
6.87%
Insider Own
13.37%
Insider Trans
0.00%
Inst Own
49.47%
Inst Trans
0.77%
ROA
6.07%
ROE
7.76%
ROIC
6.89%
Gross Margin
59.27%
Oper. Margin
3.54%
Profit Margin
4.06%
SMA20
6.39%
SMA50
6.47%
SMA200
-11.31%
Trades
Shs Outstand
10.84M
Shs Float
9.40M
52W High
6.42 -43.30%
52W Low
2.66 36.69%
Volatility
6.32% 7.11%
ATR (14)
0.23
RSI (14)
57.04
Beta
1.51
Rel Volume
0.00
Avg Volume
21.36K
Volume
0
Perf Week
9.97%
Perf Month
8.98%
Perf Quarter
26.39%
Perf Half Y
-19.82%
Perf YTD
-25.41%
Perf Year
3.12%
Perf 3Y
160.00%
Perf 5Y
-59.65%
Perf 10Y
58.48%
Prev Close
3.64
Price
3.64
Change
0.00%
Date Action Analyst Rating Change Price Target Change
Jan-26-21Initiated B. Riley Securities Buy $12.50
Jul-06-26 07:00AM
Jun-18-26 07:00AM
Jun-16-26 07:00AM
May-08-26 08:30AM
May-07-26 04:05PM
04:00PM Loading…
Apr-30-26 04:00PM
Apr-16-26 09:57AM
Apr-01-26 09:00AM
Mar-13-26 09:02PM
08:30AM
Mar-12-26 04:10PM
Mar-05-26 07:04AM
Feb-13-26 08:16AM
Dec-11-25 09:00AM
Nov-10-25 08:04PM
04:10PM Loading…
Nov-06-25 04:10PM
Oct-30-25 04:00PM
Oct-08-25 09:00AM
Oct-07-25 10:41AM
Aug-08-25 11:00PM
Aug-07-25 04:00PM
Jul-31-25 04:00PM
Jul-15-25 09:19AM
May-28-25 09:00AM
May-08-25 04:00PM
May-07-25 11:46AM
Apr-30-25 04:00PM
Apr-28-25 09:00AM
Mar-06-25 04:00PM
Mar-05-25 07:36AM
04:00PM Loading…
Feb-26-25 04:00PM
Dec-04-24 09:00AM
Nov-08-24 04:03PM
Nov-07-24 04:01PM
Nov-06-24 07:56AM
Oct-31-24 07:30AM
Oct-25-24 09:10AM
Oct-24-24 09:00AM
Oct-17-24 09:00AM
Oct-09-24 05:56PM
Aug-08-24 04:01PM
Aug-01-24 07:30AM
May-09-24 04:15PM
May-02-24 07:30AM
Apr-29-24 09:00AM
Apr-23-24 07:30AM
Mar-08-24 01:01PM
Mar-07-24 04:15PM
Feb-29-24 04:30PM
Nov-11-23 12:41PM
Nov-08-23 04:15PM
Nov-01-23 07:30AM
Oct-25-23 07:30AM
Sep-19-23 04:30PM
Aug-09-23 04:15PM
Jul-26-23 07:30AM
May-24-23 07:30AM
May-10-23 04:15PM
May-08-23 07:30AM
Apr-26-23 07:30AM
Apr-04-23 07:30AM
Mar-08-23 04:15PM
Mar-01-23 04:30PM
Feb-22-23 04:30PM
Jan-11-23 07:30AM
Nov-02-22 04:15PM
Oct-19-22 07:30AM
Oct-12-22 07:30AM
Oct-11-22 07:30AM
Sep-28-22 07:30AM
Sep-08-22 04:00PM
Aug-13-22 08:22AM
Aug-10-22 04:15PM
Jul-27-22 07:30AM
Jul-06-22 07:30AM
May-17-22 07:30AM
May-04-22 04:15PM
Apr-27-22 07:30AM
Apr-26-22 07:30AM
Mar-21-22 07:30AM
Feb-28-22 07:30AM
Feb-23-22 04:15PM
Feb-09-22 07:30AM
Jan-13-22 07:30AM
Jan-11-22 07:30AM
Nov-23-21 04:15PM
Nov-08-21 07:30AM
Nov-04-21 04:15PM
Oct-21-21 07:30AM
Oct-08-21 07:30AM
Oct-05-21 07:30AM
Sep-15-21 09:39AM
Sep-06-21 11:42AM
Sep-01-21 07:30AM
Aug-05-21 04:15PM
Jul-28-21 03:03PM
Jul-12-21 07:30AM
Jul-09-21 04:18PM
Jul-08-21 11:20AM
07:30AM
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
PresidentMr. Robert Banks
Chief Financial OfficerMs. Judy F. Krandel C.F.A.
Director of BrandBrianne McGuire
Vice President of QualityVashone R. Thomas
President of Aether Water SystemsMr. Greg Lucas
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Banks Robert R. Jr.President and CEOMar 23 '26Option Exercise1.44120,000172,800190,000Mar 25 04:54 PM
Krandel JudyChief Financial OfficerMar 23 '26Option Exercise1.7168,861117,75268,861Mar 25 04:53 PM